Welcome to our dedicated page for Legence SEC filings (Ticker: LGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Legence Corp. filings document the public-company reporting record for a Nasdaq-listed provider of engineering, consulting, installation, and maintenance services for building systems. The filings cover Class A common stock registration statements, prospectus disclosures for public equity offerings, operating and financial results, and segment information tied to Installation and Maintenance and Engineering and Consulting.
Legence's proxy and current reports address shareholder voting matters, board and committee governance, compensation arrangements, ownership and change-in-control disclosures, material agreements, and capital-structure matters involving Class A common stock, Class B common stock, and units of Legence Holdings LLC. The record also includes 8-K disclosures for earnings releases and other material events.
Legence Corp. has filed a resale prospectus covering 11,000,000 shares of Class A common stock that existing stockholders will sell to underwriters in a firm commitment offering. Legence itself is not selling shares and will receive no proceeds, while stockholders may sell up to 1,650,000 additional shares under the underwriters’ option.
The company provides engineering, installation and maintenance services for complex mechanical, electrical and plumbing systems, focusing on high‑growth sectors like data centers, technology, life sciences and healthcare. Revenue reached $2,550.5 million in 2025, with a net loss of $77.3 million and Adjusted EBITDA of $298.8 million, and backlog and awarded contracts totaled $3.7 billion at year‑end 2025.
Legence Corp. provides engineering, installation and maintenance services for complex mechanical, electrical and plumbing systems, focusing on data centers, life sciences, healthcare and education. In 2025 it generated $2.55 billion in revenue, with 42.7% from data centers and technology and 18.0% from life sciences and healthcare.
Backlog and awarded contracts reached $3.7 billion as of December 31, 2025, up 49% year over year, and the company served about 20,000 clients since 2019. Legence highlights opportunities from high-growth end markets but warns of risks from construction cyclicality, cost overruns on fixed‑price contracts, indebtedness, regulation, cybersecurity and labor relations.
Legence Corp received Amendment No. 1 to a Schedule 13G/A from The Vanguard Group reporting 0 shares beneficially owned, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, and disaggregation of certain Vanguard subsidiaries under SEC Release No. 34-39538. The amendment is signed March 27, 2026.
Legence Corp. reported strong growth for the fourth quarter and full year 2025, while remaining unprofitable. Q4 revenue reached $737.6 million, up 34.6% from a year earlier, with non-GAAP Adjusted EBITDA rising 53.2% to $87.0 million. Full-year 2025 revenue was $2.6 billion, up 21.5%, and non-GAAP Adjusted EBITDA increased 30.1% to $298.8 million. Despite this, Legence recorded a Q4 net loss attributable to the company of $32.7 million and a full-year net loss of $59.8 million. Backlog and awarded contracts climbed to a record $3.7 billion, a 48.6% increase, with a Q4 book-to-bill of 1.9x. The Installation & Maintenance segment led growth, while Engineering & Consulting grew more modestly with slightly lower margins.
Legence completed acquisitions of Metrix Engineers and, earlier in 2026, The Bowers Group, using cash and additional debt and equity. At December 31, 2025, the company held $230.2 million of cash and $825.1 million of total debt, corresponding to net leverage of 2.0x based on trailing 12‑month non-GAAP Adjusted EBITDA. Management issued first-quarter 2026 guidance for revenue of $925–$950 million and non-GAAP Adjusted EBITDA of $90–$100 million, and raised full-year 2026 guidance to revenue of $3.7–$3.9 billion and non-GAAP Adjusted EBITDA of $400–$430 million, reflecting expected contributions from recent acquisitions and strong demand in data centers, state and local government, and life sciences markets.
Legence Corp. filed an amended report to add detailed financial information for its acquisition of The Bowers Group, Inc. completed on January 2, 2026. The amendment includes Bowers’ audited 2025 results and combined pro forma figures showing how the business would affect Legence’s financials.
Bowers generated earned revenue of $766,995,789 and net income of $68,618,086 for the year ended September 30, 2025, with backlog of $1,244,157,987. Legence also provides unaudited pro forma condensed combined statements reflecting its recent IPO, corporate reorganization and acquisition financing.
Legence Corp. reported that Chief Executive Officer Jeffrey Sprau received new equity awards. He was granted employee stock options for 63,177 shares of Class A common stock at an exercise price of $50.90 per share, with 63,177 underlying shares reported following the grant. He also received 34,167 shares of Class A common stock as a grant, bringing his direct common stock holdings to 96,667 shares after the transaction. The stock options and the underlying restricted stock units vest in three substantially equal annual installments on the first, second, and third anniversaries of the award date, generally conditioned on continued employment, and the options expire on the tenth anniversary.
Legence Corp. Chief Human Resources Officer Gregory Barnes reported equity compensation awards. He received 8,123 employee stock options with an exercise price of $50.90 per share, each option tied to Class A common stock.
He was also granted 4,393 shares of Class A common stock, reported as a grant/award. Both the options and the restricted stock units vest in three substantially equal installments on each of the first, second and third anniversaries of the award date, generally contingent on continued employment. Following the stock grant, Barnes directly owns 12,429 shares of Class A common stock.
Legence Corp. General Counsel & Secretary Seki Bryce received new equity awards as part of compensation. On the award date, Bryce was granted 4,393 shares of Class A common stock in the form of restricted stock units and 8,123 employee stock options with an exercise price of $50.90 per share.
The restricted stock units each convert into one share of Class A common stock and vest in three substantially equal installments on the first, second, and third anniversaries of the grant, subject to continued employment. The options vest on the same three-year schedule and expire on the tenth anniversary of the grant date. Following these awards, Bryce directly holds 12,429 shares of Class A common stock and 8,123 stock options.
Legence Corp. Chief Accounting Officer Philippe Le Bris reported compensation-related equity awards rather than market trades. He received 3,610 employee stock options with an exercise price of $50.9000 per share, each tied to Class A common stock, and a separate grant of 1,952 Class A common shares as restricted stock units.
The restricted stock units and options vest in three substantially equal installments on each of the first, second and third anniversaries of the grant date, generally requiring continued employment through each vesting date. Following these awards, Le Bris directly holds 6,148 Class A common shares and 3,610 stock options, with the options expiring on the tenth anniversary of the award date.
Legence Corp. Chief Operating Officer Stephen Dale Hansen received new equity compensation. He was granted 15,343 employee stock options with an exercise price of $50.90 per share and 8,298 Restricted Stock Units, both vesting in three equal annual installments, generally contingent on continued employment.
Following the grant, Hansen directly holds 25,262 shares of Class A common stock and 15,343 options, aligning his compensation more closely with the company’s future share performance.